期刊文献+

抗人肝癌组织α-L-岩藻糖苷酶抗体的制备及运用

Preparation and application of a polyclonal antibody against human ɑ-L-fucosidase from primary hepatocarcinoma tissues
下载PDF
导出
摘要 目的:制备和纯化肝癌特异性α-L-岩藻糖苷酶(α-L-fucosidase,AFU)多克隆抗体及初步研究其在肝癌诊断中的临床作用。方法:用自行提取和纯化的人肝癌组织AFU免疫家兔,以间接ELISA检测抗血清效价和工作浓度。抗血清经阴离子交换法纯化后采用Western-blot鉴定纯化的AFU和免疫组化方法定位AFU在肝癌组织中的分布情况。结果:抗血清的效价和工作浓度经间接ELISA检测分别为1∶32000和1∶4000。抗血清经过饱和硫酸铵沉淀,阴离子交换树脂DEAE-52纯化后可在第115收集管前后出现一明显洗脱峰。Western-blot显示纯化的多克隆抗体可特异性地识别相对分子质量为55×103的AFU。免疫组化表明,AFU多表达于肝癌组织的细胞质和(或)胞膜而不表达于癌旁组织。结论:本实验制备的抗人肝癌组织AFU多克隆抗体可用于检测肝癌组织和血清中AFU的表达水平。 OBJECTIVE: To prepare and purify a polyclonal antibody against α-L-fucosidase (AFU) from human liver cancer tissue and detect the localization of AFU in the tumorous tissues. METHODS: A polyclonal antibody was raised against purified AFU by immunizing the rabbit and obtained by anion exchange chromatography on DEAE-52 with stepwise elution after saturated ammonium sulfate fractionation. The working concentration of polyclonal antibody was measured by u- sing indirect ELISA. Expression of AFU in the malignant and adjacent liver tissues was observed by the immuohistochemical staining using purified antiserum as a primary antibody. RESULTS: The titer and working concentration of the polyclonal antibody measured by indirect ELISA were 1 : 32 000, 1 : 4 000, respectively. Western-blot analysis indicated that the polyclonal antibody can recognize one protein band of Mr 55× 10^3. Expression of AFU was observed in the cytoplasm and/or cell membrane of liver cancer tissues but not in that of adjacent tissues. CONCLUSION:The polyclonal antibody against AFU prepared in this experiment has high specificity and can be applied to the diagnosis of HCC by indirect ELISA.
出处 《中华肿瘤防治杂志》 CAS 2006年第9期641-644,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 国家863计划课题项目(2002AA2Z2011)
关键词 肝肿瘤 实验性 多克隆抗体 α—L-岩藻糖苷酶 liver neoplasms, experimental polyclonal antibody α-L-fucosidase
  • 相关文献

参考文献12

  • 1Alhadeff J A.Structure and function of mammalian alpha -L-fucosidase[J].Trends in Comparative Biochem & Physiol,1998,4:105-118.
  • 2Giardina M G,Matarazzo M,Morante R,et al.Serum alpha-Lfucosidase activity and early detection of hepatocellular carcinoma:a prospective study of patients with cirrhosis[J].Cancer,1998,83(12):2468-2474.
  • 3Ayude D,Paez-De-La-Cadena M,Martinez-Zorzano V S,et al.Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer[J].Oncology,2003,64(1):36-45.
  • 4Abdel-Aleem H,Ahmed A,Sabra A M,et al.Serum alpha-L-fucosidase enzyme activity in ovarian and other female genital tract tumors[J].Int J Gynaecol Obstet,1996,55(3):273-279.
  • 5李超,林菊生,陈孝平,易继林,陶璐薇.人肝癌组织α-L-岩藻糖苷酶的提取和鉴定[J].世界华人消化杂志,2005,13(9):1089-1093. 被引量:2
  • 6沈关心 周汝麟.现代免疫学实验技术[M](第2版)[M].武汉:湖北科学技术出版社,2002.410-411.
  • 7J萨姆布鲁克 E F 弗里奇 T 曼尼阿蒂斯 金冬雁 黎孟枫 译.分子克隆实验指南[M](第2版)[M].北京:科学出版社,1996..
  • 8Fernández J,Rodríguez-Berrocal F J,de-Carlos A,et al.Nonradioactive immunoquantification of alpha -L-fucosidase protein in human colon tissues[J].J Biochem Biophys Meth,1996,31 (1-2):39-47.
  • 9Johnson S W,Piesecki S,Wang R F,et al.Analysis of purified human liver alpha-L-fucosidase by western-blotting with lectins and polyclonal and monoclonal antibodies[J].Biochem J,1992,282 (Pt 3):829-834.
  • 10Takahashi H,Saibara T,Iwamura S,et al.Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma[J].Hepatology,1994,19(6):1414-1417.

二级参考文献32

  • 1Seo HC, Willems PJ, Kretz KA, Martin BM, O'Brien JS.Fucosidosis: four new mutations and a new polymorphism.Hum Mol Genet 1993;2:423-429.
  • 2Giardina MG, Matarazzo M, Varriale A, Morante R, Napoli MD, Martino R. Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma. Cancer 1992;70:1044-1048.
  • 3Giardina MG, Matarazzo M, Morante R, Lucariello A, Varriale A, Guardasole V, De Marco G. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma:a prospective study of patients with cirrhosis. Cancer 1998;83:2468-2474.
  • 4Deugnier Y, David V, Brissot P, Mabo P, Delamaire D, Messner M, Bourel M, Legall JY. Serum alpha-L-fucosidase: A new marker for the diagnosis of primary hepatic carcinoma?Hepatology/ 1984;4:889-892.
  • 5Bukvfzer S, Stass PM, Kew MC, de Beer M, Groeneveld HT.Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks. Br J Cancer 1989;59:417-420.
  • 6Leray G, Deugnier Y, Jouanolle AM, Lehry D, Bretagne JF,Campion JP, Brissot P, Le Treut A. Biochemical aspects of alpha-L-fucosidase in hepatocellular carcinoma. Hepatology 1989;9:249-252.
  • 7Di Matteo G, Orfeo MA, Romeo G. Human alpha-L-fucosidase purification and properties. Biochim Biophys Acta 1976;429:527-537.
  • 8Alhadeff JA, Janowky AJ. Human serum alpha-L-fucosidase.Clin Chim Acta 1978;82:133-140.
  • 9Abdel-Aleem H, Ahmed A, Sabra AM, Zakhari M, Soliman M, Hamed H. Serum alpha-L-fucosidase enzyme activity in ovarian and other female genital tract tumors. Int J Gynecol Obstetrics 1996;55:273-279.
  • 10Ayude D, Fernandez-Rodriguez J, Rodriguez-Berrocal FJ,Martinez-Zorzano VS, de Carlos A, Gil E, de la Cadena MP.Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer. Oncology 2000;59:310-316.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部